1.Danqi Xinmaikang Attenuates Chronic Heart Failure by Promoting Fatty Acid Oxidation Through Activating AMPK/PGC-1α Signaling Pathway
Xiuqin ZHOU ; Yinzhi SONG ; Cuiling LIU ; Zhifang TANG ; Zhongqiu LIU ; Rong ZHANG ; Yuanyuan CHENG ; Qi LIANG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(24):93-103
ObjectiveTo investigate the effects of Danqi Xinmaikang (DQ) on chronic heart failure (CHF) induced by left anterior descending (LAD) coronary artery ligation in mice and to explore its molecular mechanism of regulating fatty acid oxidation via the adenosine 5'-monophosphate-activated protein kinase (AMPK) signaling pathway to combat CHF. MethodsA CHF model was established in mice by LAD coronary artery ligation. Mice were randomized into sham, model, positive control (sacubitril valsartan sodium tablets 50 mg·kg-1), and low-dose and high-dose DQ groups(0.64,1.28 g·kg-1), with 6 mice in each group. After successful modeling, drug administration was implemented for 4 consecutive weeks. After drug administration, changes in cardiac function parameters such as left ventricular ejection fraction (LVEF) and left ventricular fractional shortening (LVFS) were measured via cardiac ultrasound. Plasma N-terminal pro-B-type natriuretic peptide precursor (NT-proBNP) levels were determined by enzyme-linked immunosorbent assay (ELISA). Cardiac pathological changes and fibrosis severity were observed via hematoxylin-eosin (HE) staining and Masson staining. Western blot and Real-time quantitative polymerase chain reaction(Real-time PCR) were adopted to determine the protein and mRNA levels, respectively, of AMPK, phosphorylated AMPK (p-AMPK), medium-chain specific acyl-CoA dehydrogenase, mitochondrial (ACADM), carnitine palmitoyltransferase 1A (CPT1A), fatty acid translocase (CD36), and peroxisome proliferator-activated receptor γ co-activator 1α (PGC-1α). In vitro experiments employed oxygen-glucose deprivation (OGD) to treat cardiomyocytes, with control, OGD model group, and low-, medium-, and high-dose (1, 3, and 5 g·L-1, respectively) DQ groups established. The expression of relevant molecules in each group was assessed via Western blot and Real-time PCR. AMPK inhibitor Compound C (CC) was further used to verify the role of AMPK pathway in the protective effect of DQ. ResultsCompared with the sham group, the model group exhibited reduced LVEF and LVFS (P<0.05) and an elevated plasma NT-proBNP level (P<0.05), along with significant pathological damage and fibrosis in the myocardial tissue. Compared with the model group, 4 weeks of DQ treatment improved LVEF and LVFS (P<0.05), decreased the plasma NT-proBNP level (P<0.05), and alleviated myocardial fibrosis and pathological damage. In vitro experiments similarly demonstrated that DQ significantly enhanced the cell viability of OGD-treated H9c2 cells compared with the OGD group(P<0.05). Further mechanism studies revealed that DQ, both in vitro and in vivo, promoted AMPK phosphorylation and increased mRNA and protein levels of PGC-1α and fatty acid oxidation-related molecules (ACADM, CPT1A, and CD36) (P<0.05). The AMPK inhibitor Compound C reversed these effects of DQ (P<0.05). ConclusionDanqi Xinmaikang effectively improves the cardiac function in the mouse model of LAD ligation-induced CHF, reduces myocardial injury and fibrosis, and exhibits significant protective effects against OGD-induced cardiomyocyte damage. It activates the AMPK/PGC-1α signaling pathway to promote fatty acid oxidation, thereby ameliorating myocardial energy metabolism disorders. In this study, DQ was associated with ischemic heart failure, providing experimental basis for CHF treatment, suggesting that it has the potential to be a candidate drug for CHF treatment.
2.Expression and significance of histidine decarboxylase in liver and intestinal tissue in rats with strangulated intestinal obstruction
Yinzhi JIN ; Yang ZHAO ; Bin SONG
International Journal of Surgery 2015;42(7):442-445,封3
Objective To investigate the expression and significance of Histidine decarboxylase (HDC) in liver and intestinal tissue for early diagnosis of strangulated intestinal obstruction.Methods Ten male Wistar rats for the control group and 20 ones for the test group which was divided into A,B groups.Group A (n =10) was made by using ligating ileum for 1 h and group B (n =10) was for 3 h.When intestinal ob struction models were built,the changes of pathology in liver and intestine tissue were observed by light microscope.Real time quantitative PCR was used to detect the expression of HDC in liver and intestinal tissue.Results Under light microscopic level,the injury score of intestine in test group was increased in comparison with that in control group.At 3 h after strangulated intestinal obstruction,RT-PCR showed that brightness of HDC band in intestine tissue was significantly higher than the control.Real time quantitative PCR also showed that the expression of HDC in liver tissue in group A and group B increased 1.34 fold(P >0.05) and 2.21 fold (P < 0.05) respectively,when compared with the control group.The expression of HDC in intestine tissue in group A and group B increased 1.81 fold(P > 0.05) and 8.02 fold (P < 0.01) respectively,when compared with the control group.Conclusion Expression of HDC can be used for early diagnosis of strangulated intestinal obstruction.

Result Analysis
Print
Save
E-mail